Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice

Gastroenterology

Volumn 150, Issue 5, 2016, Pages 1208-1218

  Fan, Yanbo ^a   Lu, Haocheng ^a   Guo, Yanhong ^a   Zhu, Tianqing ^a   Garcia Barrio, Minerva T ^b   Jiang, Zhisheng ^c   Willer, Cristen J ^a,d   Zhang, Jifeng ^a   Eugene Chen, Y ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gene Regulation; Lipid Disorder; Membrane Proteins; Translational Research

Indexed keywords

7 DEHYDROCHOLESTEROL; ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CYTOCHROME P450; CYTOCHROME P450 FAMILY 2 SUBFAMILY C POLYPEPTIDE 54; EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 3; GLUCOSE REGULATED PROTEIN 78; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INITIATION FACTOR; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEUS SIGNALING 1; TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; BIOLOGICAL MARKER; TM6SF2 PROTEIN, HUMAN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CRISPR CAS SYSTEM; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; LIVER HISTOLOGY; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UNFOLDED PROTEIN RESPONSE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; DEFICIENCY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GENOTYPE; HUMAN; KNOCKOUT MOUSE; LIPID DIET; LIVER; METABOLISM; PHENOTYPE; TIME FACTOR;

ANIMALS; BIOMARKERS; CELL LINE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; LIVER; MALE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; TIME FACTORS; TRANSFECTION; TRIGLYCERIDES;

EID: 84962142324     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.01.005     Document Type: Article

References (45)

1. A. Rohatgi, A. Khera, J.D. Berry, and et al. HDL cholesterol efflux capacity and incident cardiovascular events N Engl J Med 371 2014 2383 2393
2. A.M. Gotto Jr. Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F. Bishop Lecture J Am Coll Cardiol 46 2005 1219 1224
3. F.H. Rached, M.J. Chapman, and A. Kontush An overview of the new frontiers in the treatment of atherogenic dyslipidemias Clin Pharmacol Ther 96 2014 57 63
4. O.L. Holmen, H. Zhang, Y. Fan, and et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk Nat Genet 46 2014 345 351
5. J. Kozlitina, E. Smagris, S. Stender, and et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease Nat Genet 46 2014 352 356
6. B. Kahali, Y.L. Liu, A.K. Daly, and et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology 148 2015 679 684
7. V.W. Wong, G.L. Wong, C.H. Tse, and et al. Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese J Hepatol 61 2014 708 709
8. A. Grandone, D. Cozzolino, P. Marzuillo, and et al. TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children Pediatr Obes 11 2016 115 119
9. P. Dongiovanni, S. Petta, C. Maglio, and et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease Hepatology 61 2015 506 514
10. M. Goffredo, S. Caprio, A.E. Feldstein, and et al. Role of the TM6SF2 rs58542926 in the pathogenesis of non-alcoholic pediatric fatty liver disease (NAFLD): a multiethnic study Hepatology 63 2016 117 125
11. C.J. Pirola, and S. Sookoian The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis Hepatology 62 2015 1742 1756
12. H. Mahdessian, A. Taxiarchis, S. Popov, and et al. TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content Proc Natl Acad Sci U S A 111 2014 8913 8918
13. C.A. Pinkert, D.M. Ornitz, R.L. Brinster, and et al. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice Genes Dev 1 1987 268 276
14. D. Yang, J. Xu, T. Zhu, and et al. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases J Mol Cell Biol 6 2014 97 99
15. R. Buettner, J. Scholmerich, and L.C. Bollheimer High-fat diets: modeling the metabolic disorders of human obesity in rodents Obesity (Silver Spring) 15 2007 798 808
16. C. Thomas, R. Pellicciari, M. Pruzanski, and et al. Targeting bile-acid signalling for metabolic diseases Nat Rev Drug Discov 7 2008 678 693
17. Y.L. Liu, H.L. Reeves, A.D. Burt, and et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309
18. Y.S. Roh, R. Loomba, and E. Seki The TM6SF2 variants, novel genetic predictors for nonalcoholic steatohepatitis Gastroenterology 148 2015 252 254
19. E.M. Brunt Nonalcoholic steatohepatitis Semin Liver Dis 24 2004 3 20
20. D.E. Kleiner, and P. Bedossa Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists Gastroenterology 149 2015 1305 1308
21. C. Baeck, A. Wehr, K.R. Karlmark, and et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury Gut 61 2012 416 426
22. J.W. Haukeland, J.K. Damas, Z. Konopski, and et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 J Hepatol 44 2006 1167 1174
23. V. Braunersreuther, G.L. Viviani, F. Mach, and et al. Role of cytokines and chemokines in non-alcoholic fatty liver disease World J Gastroenterol 18 2012 727 735
24. L. Sanchez-Pulido, and C.P. Ponting TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease Front Genet 5 2014 439
25. H. Yoshida, T. Matsui, A. Yamamoto, and et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor Cell 107 2001 881 891
26. H. Wang, Y. Zhao, J.A. Bradbury, and et al. Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities Mol Pharmacol 65 2004 1148 1158
27. Q. Liu, B. Yuan, K.A. Lo, and et al. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism Proc Natl Acad Sci U S A 109 2012 14568 14573
28. J.A. Hubacek, K.E. Berge, J.C. Cohen, and et al. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia Hum Mutat 18 2001 359 360
29. L. Yu, K. von Bergmann, D. Lutjohann, and et al. Selective sterol accumulation in ABCG5/ABCG8-deficient mice J Lipid Res 45 2004 301 307
30. T.M. Teslovich, K. Musunuru, A.V. Smith, and et al. Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
31. A.G. Jay, A.N. Chen, M.A. Paz, and et al. CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding J Biol Chem 290 2015 4590 4603
32. M.E. Miquilena-Colina, E. Lima-Cabello, S. Sanchez-Campos, and et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C Gut 60 2011 1394 1402
33. J. Zhou, M. Febbraio, T. Wada, and et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis Gastroenterology 134 2008 556 567
34. P. Dongiovanni, S. Romeo, and L. Valenti Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis Biomed Res Int 2015 2015 460190
35. M. Milano, A. Aghemo, R.M. Mancina, and et al. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients Hepatology 62 2015 111 117
36. A.K. Daly, C.P. Day, Y.L. Liu, and et al. TM6SF2 as a genetic risk factor for fibrosis Hepatology 62 2015 1321
37. N. Coppola, Z. Rosa, G. Cirillo, and et al. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism Liver Int 35 2015 1959 1963
38. S. Buch, F. Stickel, E. Trepo, and et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis Nat Genet 47 2015 1443 1448
39. M.N. VanSaun, I.K. Lee, M.K. Washington, and et al. High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model Am J Pathol 175 2009 355 364
40. A. Dela Pena, I. Leclercq, J. Field, and et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis Gastroenterology 129 2005 1663 1674
41. E. Ip, G. Farrell, P. Hall, and et al. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice Hepatology 39 2004 1286 1296
42. N. Matsuzawa, T. Takamura, S. Kurita, and et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet Hepatology 46 2007 1392 1403
43. Y. Takahashi, Y. Soejima, and T. Fukusato Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis World J Gastroenterol 18 2012 2300 2308
44. L. Fontana, E. Zhao, M. Amir, and et al. Aging promotes the development of diet-induced murine steatohepatitis but not steatosis Hepatology 57 2013 995 1004
45. R.M. Mancina, F. Sentinelli, M. Incani, and et al. Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children Dig Liver Dis 48 2016 100 101